Symmetry Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Symmetry Partners's MRK Position: Q2 2026 in Review
Symmetry Partners increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $153K and bringing the position to 14,297 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #65.
Symmetry Partners first reported a position in MRK in Q4 2018 and has held it in 29 quarters since. The position peaked at $9.43M in Q2 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Symmetry Partners held 14,297 shares of Merck worth $1.84M as of Q2 2026.
- Symmetry Partners bought 1,303 Merck shares in Q2 2026, an estimated $153K.
- Merck made up 0.09% of Symmetry Partners's portfolio in Q2 2026, its #65 holding.
- Symmetry Partners first reported a position in Merck in Q4 2018 and has held it in 29 quarters since.
- Symmetry Partners's Merck position peaked at $9.43M in Q2 2023.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.